GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Gross-Profit-to-Asset %

Sinew Pharma (ROCO:6634) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sinew Pharma's annualized Gross Profit for the quarter that ended in Dec. 2024 was NT$0.00 Mil. Sinew Pharma's average Total Assets over the quarter that ended in Dec. 2024 was NT$1,259.71 Mil. Therefore, Sinew Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 0.00%.


Sinew Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Sinew Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Gross-Profit-to-Asset % Chart

Sinew Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.50 0.02 - -

Sinew Pharma Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sinew Pharma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Sinew Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinew Pharma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinew Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sinew Pharma's Gross-Profit-to-Asset % falls into.


;
;

Sinew Pharma Gross-Profit-to-Asset % Calculation

Sinew Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=0/( (1363.375+1226.142)/ 2 )
=0/1294.7585
=0.00 %

Sinew Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (1293.287+1226.142)/ 2 )
=0/1259.7145
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Sinew Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinew Pharma Business Description

Traded in Other Exchanges
N/A
Address
C516, Building C, Number 99, Lane 130, Section 1, Xueyin Road, Nangang District, Taipei, TWN, 11571
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma Headlines

No Headlines